Le Lézard
Classified in: Health
Subjects: CALENDAR OF EVENTS, HEALTH, SPORTS

Swinging for Hope ? Bunzl Raises Record Funds for Revolutionary Pediatric Brain Tumour Treatment


BURLINGTON, Ontario, July 13, 2023 (GLOBE NEWSWIRE) -- Bunzl Canada is proud to have hosted its 23rd annual Ripple of Hope golf tournament in support of the Arthur & Sonia Labatt Brain Tumour Research Centre at Toronto's Hospital for Sick Children.

On July 11th, Bunzl Canada, its vendor partners, and customers of its cleaning and hygiene, safety, industrial, grocery/retail/processor business segments gathered at Greystone Golf Club in Milton, Ontario. Participants enjoyed a day of golf, fundraised and increased awareness for Toronto SickKids' advanced pediatric brain tumour research initiatives.

Over the last two decades, Bunzl Canada and its supporters have raised over $1.75 million to fund the revolutionary work at SickKids Hospital to combat life-threatening pediatric neurosurgical conditions. This year's 23rd annual tournament surpassed $60,000 in donations alone.

Distinguished as the world's largest research centre for brain tumour research, the team at Toronto's SickKids Hospital, led by Dr. James Rutka, has led to the discovery and development of MRI-guided focused ultrasound technology to treat children with brain tumours. This revolutionary breakthrough offers a less intrusive way to deliver targeted chemotherapy to aggressive and terminal Diffuse Intrinsic Pontine Glioma (DIPG) pediatric brain tumour.

Since the last annual fundraising event, Dr. Rutka and his team, in partnership with the Sunnybrook Health Sciences Centre, received approval to begin a world first clinical trial with the newly developed MRI-guided technology.

"I'm very pleased today to announce that we've enrolled the first patient on this clinical trial. This is the first patient in the world who has been treated for this disease with this [MRI-guided] technology," said Dr. Rutka.

"I've been at this for over 30 years, and this is the first time in my career I've been able to take a research breakthrough from the bench to the bedside, treating the very first patient in the world with this novel strategy," said Dr. Rutka.

MRI-guided focused ultrasound technology allows doctors to bypass the blood-brain barrier and directly target aggressive tumours within the brain stem. Dr. Rutka and the research team at Toronto's SickKids Hospital plan to continue clinical trials of this transformative treatment, and hope to open the trial worldwide.

"Bunzl has been amazing in its support of our research efforts over more than 20 years now which is pivotal for us to do these types of clinical trials," said Dr. Rutka. "Without that support, we wouldn't be talking about going from concept to clinical trial as we can today."

"Words can't express our appreciation for the support and contributions from our vendor partners and customers," said John Howlett, Bunzl Canada's President. "We're excited to continue to support Dr. Rutka and his amazing team at SickKids Hospital as they continue to develop revolutionary treatments for children battling this devastating disease."

About Bunzl Canada

Bunzl Canada Inc. (bunzlcanada.ca) provides the cleaning and hygiene products and equipment, food and retail packaging, safety products and industrial supplies which keep over 45,000 Canadian businesses running optimally, every day. The company brings its customers the advantage of global sourcing, product innovation and national scale combined with responsive local service and deep category expertise. Bunzl Canada Inc. is a division of Bunzl Distribution USA, LLC.

About Bunzl Distribution

Bunzl Distribution USA, LLC (bunzldistribution.com), headquartered in St. Louis, Mo., is the largest division of London-based Bunzl plc, an international distribution and outsourcing group. With more than 100 distribution centre throughout the U.S., Canada, Mexico and the Caribbean, Bunzl supplies a wide range of products to food processors, supermarkets, retailers, convenience stores and other users.

Media Inquiries

Margo Hunnisett
Vice President, Marketing & Communications
Bunzl Canada Inc.
[email protected]
(905) 630-3749




Photos accompanying this announcement are available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/72d6131b-801f-469a-9088-cd6c8f5f06f8

https://www.globenewswire.com/NewsRoom/AttachmentNg/84bf2796-0de9-4bc0-9e5a-0774daa81485

https://www.globenewswire.com/NewsRoom/AttachmentNg/ad59adeb-6daa-4469-9bae-3e010bce175b

https://www.globenewswire.com/NewsRoom/AttachmentNg/45563fca-8de4-4fe5-bc94-571ec52e05dc

https://www.globenewswire.com/NewsRoom/AttachmentNg/721a6330-1095-4fe0-b030-c5cdc9952a50

https://www.globenewswire.com/NewsRoom/AttachmentNg/0bfc1cd7-3ead-4dd5-b268-4de7ce31f585



These press releases may also interest you

at 09:30
Life Time Group Holdings, Inc. today announced the webcast information for its Investor and Analyst Day taking place on Thursday, May 30, 2024. As shared during its first quarter financial results call on May 1, 2024, Life Time will host the...

at 09:30
Notable, the AI platform for healthcare operations, today announced a new partnership with Beacon Health System, a locally owned and operated not-for-profit health care system serving more than 4,000 patients daily in northwest Indiana and southern...

at 09:30
Prevent Blindness, the nation's leading nonprofit eye health and safety organization, has created new educational materials on Stargardt disease, a form of inherited retinal disease (IRD). Coinciding with May's IRD Genetic Testing...

at 09:20
Be Biopharma, Inc. ("Be Bio"), a company pioneering the discovery and development of Engineered B Cell Medicines (BCMs), today announced the addition of Paula Cannon, Ph.D., to its Scientific Advisory Board. Dr. Cannon, Distinguished Professor of...

at 09:20
Qurient Co. Ltd. (KRX: 115180), a clinical-stage biotech company based in Korea, entered into a Cooperative Research and Development Agreement (CRADA) with the U.S. National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to...

at 09:17
Lansinoh Laboratories, a longtime leader in postpartum and breastfeeding solutions, today announced its pursuit of strategic acquisition opportunities to broaden its portfolio into nutrition and wellness solutions that support women along their...



News published on and distributed by: